Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
for Chronic Neuropathic Pain
11 locations incl. Scottsdale
Sponsor: Sangamo Therapeutics
Sex: All·Age: 18+
Code: NCT06980948·Phase 1, Phase 2·Recruiting